| 000 | 01345 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250512232813.0 | ||
| 264 | 0 | _c19810827 | |
| 008 | 198108s 0 0 eng d | ||
| 022 | _a0008-543X | ||
| 024 | 7 |
_a10.1002/1097-0142(19810715)48:2<252::aid-cncr2820480207>3.0.co;2-m _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSalmassi, S | |
| 245 | 0 | 0 |
_aManagement of Hodgkin's disease in a patient with sickle cell anemia. _h[electronic resource] |
| 260 |
_bCancer _cJul 1981 |
||
| 300 |
_a252-4 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnemia, Sickle Cell _xblood |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aBlood Group Incompatibility _xcomplications |
| 650 | 0 | 4 | _aBlood Transfusion |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aErythrocyte Transfusion |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHodgkin Disease _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKell Blood-Group System |
| 650 | 0 | 4 | _aRh-Hr Blood-Group System |
| 700 | 1 | _aCurrie, E T | |
| 700 | 1 | _aBolf, E C | |
| 700 | 1 | _aHernandez, M | |
| 700 | 1 | _aKasprisin, D O | |
| 773 | 0 |
_tCancer _gvol. 48 _gno. 2 _gp. 252-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/1097-0142(19810715)48:2<252::aid-cncr2820480207>3.0.co;2-m _zAvailable from publisher's website |
| 999 |
_c6786483 _d6786483 |
||